OptiBiotix Secures First US Order for SlimBiome® with Leading Weight Management Brand

OptiBiotix Health ( (GB:OPTI) ) has issued an announcement.

OptiBiotix Health plc has received its first order from a leading US weight management brand for its product SlimBiome®, which will be used in a range of flavored drinks aimed at reducing hunger. This development marks a significant step for OptiBiotix as it positions SlimBiome® within a major US brand, highlighting the demand for natural, science-backed appetite control products in the evolving weight management market. The company anticipates further orders and product launches in 2025, reflecting growing interest from major brands worldwide.

More about OptiBiotix Health

OptiBiotix Health plc, established in March 2012, operates in the life sciences sector, focusing on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks, with a focus on obesity, cardiovascular health, and diabetes.

YTD Price Performance: -11.11%

Average Trading Volume: 273,822

Technical Sentiment Signal: Strong Buy

Current Market Cap: £15.67M

For an in-depth examination of OPTI stock, go to TipRanks’ Stock Analysis page.